Events & Webinars
|Recognizing Safety Risks and Taking Action to Maximize the Benefits of Smart Pump Technology
Monday, December 4, 2017 - 11:30am-1:00pm ET
Healthcare organizations often do not use smart infusion pump technology to its full potential, which sometimes results in serious intravenous medication errors and associated patient harm. As such, it is important to optimize the safety benefits of smart pumps while ensuring readiness for integration with other available technologies, such as computerized prescriber order entry (CPOE) systems and electronic health records (EHRs). This symposium will address current safety issues due to smart pump underutilization, the implementation of a comprehensive drug library to promote compliance, methods to analyze pump data to investigate the use of best practices, and the steps pharmacists can take now in preparation for future technology interoperability.
The target audience for this activity includes pharmacists and pharmacy technicians in health-system settings. At the completion of this symposium, the participant will be able to:
10:45am - Doors open
Topics and Faculty
Smart Pump Technology: Recognizing the Gains and Addressing the Gaps
Pharmacists and Pharmacy Technicians
This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-411-L05-P/T has been assigned to this knowledge-based live CE activity (initial release date December 4, 2017). This CE activity is approved for 1.5 contact hours (0.15 CEUs) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Successful completion of the online post-test and evaluation at www.ProCE.com no later than January 5, 2018 is required to receive CE credit. CE credit will be automatically uploaded to NABP/CPE Monitor upon completion of the post-test and evaluation. No partial credit will be given.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Conflict of interest disclosures are required of all faculty and shall be provided to all participants at the conference.
This symposium is funded through an educational grant from Baxter Healthcare Corporation.